Torrent Pharmaceuticals Ltd

• Country

  India

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Pharmaceuticals

• Sub-sector

  Health Care

• Capitalization (millions of $)

  10470.1

• Ticker

  TORP.NS

• ISIN

  INE685A01028

• IPO date

  1994-11-03

• Availability on Russian exchanges

  No

• Reporting for

  2024-02-02

• Date fact. publication of reports

  2023-12-31

Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The Company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments. The Company offers products in various categories, including tablets, capsule and parenteral. Its geographical segments include India and outside India. It manufactures various active pharmaceutical ingredients (APIs), such as Nicorandil, Risperidone, Venlafaxine Hydrochloride, Ropinarole Hydrochloride, Duloxetine Hydrochloride, Ormeloxifen Hydrochloride, Nebivolol Hydrochloride, Lamotrigine and Sertraline Hydrochloride. The Company's subsidiaries include Heumann Pharma GmbH & Co., Torrent Pharma GmbH, Heunet Pharma GmbH, Norispharm GmbH, Torrent Pharma (Thailand) Co. Ltd., Torrent Pharma S.R.L., Aptil Pharma Limited and Laboratories Torrent Malaysia Sdn. Bhd.